The Cooper Companies, Inc. (NASDAQ:COO) Shares Sold by Kentucky Retirement Systems Insurance Trust Fund

Kentucky Retirement Systems Insurance Trust Fund trimmed its position in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 8.0% in the 3rd quarter, Holdings Channel.com reports. The firm owned 5,895 shares of the medical device company’s stock after selling 516 shares during the period. Kentucky Retirement Systems Insurance Trust Fund’s holdings in Cooper Companies were worth $650,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also recently made changes to their positions in the company. Capital World Investors boosted its position in Cooper Companies by 301.7% during the first quarter. Capital World Investors now owns 5,654,023 shares of the medical device company’s stock worth $573,657,000 after purchasing an additional 4,246,519 shares in the last quarter. Janus Henderson Group PLC lifted its position in shares of Cooper Companies by 279.8% during the 1st quarter. Janus Henderson Group PLC now owns 3,437,064 shares of the medical device company’s stock valued at $348,723,000 after buying an additional 2,532,186 shares in the last quarter. Swedbank AB acquired a new stake in Cooper Companies in the 1st quarter valued at $139,246,000. Point72 Asset Management L.P. grew its stake in Cooper Companies by 480.1% in the 2nd quarter. Point72 Asset Management L.P. now owns 937,806 shares of the medical device company’s stock valued at $81,870,000 after acquiring an additional 776,140 shares during the period. Finally, Victory Capital Management Inc. increased its holdings in Cooper Companies by 23.0% in the 3rd quarter. Victory Capital Management Inc. now owns 3,950,119 shares of the medical device company’s stock worth $435,856,000 after acquiring an additional 737,726 shares in the last quarter. 24.39% of the stock is currently owned by institutional investors and hedge funds.

Cooper Companies Stock Down 0.2 %

Shares of COO opened at $99.48 on Tuesday. The stock has a fifty day simple moving average of $106.66 and a two-hundred day simple moving average of $98.12. The company has a quick ratio of 1.18, a current ratio of 1.99 and a debt-to-equity ratio of 0.33. The company has a market capitalization of $19.81 billion, a PE ratio of 55.42, a price-to-earnings-growth ratio of 2.15 and a beta of 0.99. The Cooper Companies, Inc. has a 52-week low of $82.21 and a 52-week high of $112.38.

Cooper Companies (NASDAQ:COO) last issued its earnings results on Wednesday, August 28th. The medical device company reported $0.96 EPS for the quarter, topping analysts’ consensus estimates of $0.91 by $0.05. Cooper Companies had a net margin of 9.45% and a return on equity of 9.08%. The company had revenue of $1 billion for the quarter, compared to the consensus estimate of $997.30 million. During the same period in the previous year, the firm earned $0.84 earnings per share. Cooper Companies’s quarterly revenue was up 7.8% compared to the same quarter last year. As a group, equities analysts forecast that The Cooper Companies, Inc. will post 3.65 EPS for the current year.

Insider Activity

In related news, COO Daniel G. Mcbride sold 114,992 shares of the business’s stock in a transaction dated Wednesday, September 4th. The shares were sold at an average price of $105.48, for a total value of $12,129,356.16. Following the sale, the chief operating officer now directly owns 44,696 shares in the company, valued at approximately $4,714,534.08. The trade was a 72.01 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Brian G. Andrews sold 24,788 shares of the stock in a transaction dated Thursday, September 5th. The stock was sold at an average price of $105.90, for a total transaction of $2,625,049.20. Following the transaction, the chief financial officer now directly owns 6,614 shares of the company’s stock, valued at approximately $700,422.60. This trade represents a 78.94 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 256,373 shares of company stock valued at $27,637,427. 2.00% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

COO has been the topic of several research analyst reports. Wells Fargo & Company lifted their target price on shares of Cooper Companies from $110.00 to $115.00 and gave the company an “overweight” rating in a research report on Thursday, August 29th. Needham & Company LLC reiterated a “hold” rating on shares of Cooper Companies in a research note on Thursday, August 29th. Morgan Stanley raised their target price on Cooper Companies from $95.00 to $104.00 and gave the company an “equal weight” rating in a research report on Tuesday, September 10th. Robert W. Baird boosted their price target on Cooper Companies from $118.00 to $125.00 and gave the stock an “outperform” rating in a research report on Thursday, August 29th. Finally, Stifel Nicolaus restated a “buy” rating and issued a $115.00 price objective (up previously from $110.00) on shares of Cooper Companies in a report on Thursday, August 29th. Three analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $117.00.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.